It's time

AAPS Journal

Volumn 7, Issue 3, 2005, Pages

  Smith, Brian P ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Mechanistic models; Statistical inference

Indexed keywords

PLACEBO; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ARTICLE; BAYES THEOREM; CLINICAL PHARMACOLOGY; CLINICAL RESEARCH; CLINICAL TRIAL; COMPUTER PROGRAM; CONCENTRATION RESPONSE; CONFIDENCE INTERVAL; COST CONTROL; DATA ANALYSIS; HUMAN; HYPOTHESIS; MEDICAL DECISION MAKING; NONLINEAR SYSTEM; PHARMACODYNAMICS; PROBABILITY; QUANTITATIVE ANALYSIS; SAMPLE SIZE; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; BIOLOGICAL MODEL; STATISTICS;

ANALYSIS OF VARIANCE; CONFIDENCE INTERVALS; MODELS, BIOLOGICAL; PHARMACOLOGY, CLINICAL;

EID: 33644798934     PISSN: 15221059     EISSN: 15221059     Source Type: Journal    
DOI: 10.1208/aapsj070365     Document Type: Article

References (6)

1. Salsburg D. The Lady Tasting Tea: How Statistics Revolutionized Science in the Twentieth Century. New York: Henry Holt and Company; 2002.
2. Matthey S. p<.05 - But is it clinically significant? Practical examples for clinicians. Behav Change. 1998;15:140-146.
3. Dixon P. The p-value fallacy and how to avoid it. Can J Exp Psychol. 2003;57:189-202.
4. Moyé LA. Multiple Analyses in Clinical Trials. New York: Springer-Verlag; 2003.
5. O'Hagan A, Luce BR. A Primer on Bayesian Statistics in Health Economics and Outcomes Research. Sheffield: Centre for Bayesian Statistics in Health Economics 2003; Available at: http://www.shef.ac.uk/~st1ao/pdf/primer.pdf. Accessed June 1, 2005.
6. SAS/STAT User's Guide. Version 8. Cary, NC: SAS Institute Inc; 1999.